ArticleDrug design, development and therapy2026

Findings Interpretation Concerns Regarding the Emulated Target Trial of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Psoriatic Arthritis [Letter].

Anastasios Lymperopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.